About this trial
This clinical trial aims to investigate whether an integrative approach combining education on the Mediterranean diet and physical activity (PA) can significantly reduce depressive symptomatology in individuals with major depressive disorder. The study will evaluate changes in depressive symptoms and assess biological modulations, including alterations in the gut microbiota and inflammatory markers, resulting from the PA intervention.
Participants will be randomized into two arms: the active control group will attend a series of lessons focused on the Mediterranean diet, while the experimental group will participate in the same dietary lessons combined with a structured PA program of 12 weeks.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Primary diagnosis of depression (DSM-5 criteria, American Psychiatric Association 2013).
Depressive symptoms assessed using MADR, BDI, or ZDR scales.
Ability to provide written informed consent.
Self-reported moderate-intensity leisure physical activity of less than 150 minutes per week.
Disqualifiers
Patients with severe psychopathology.
Medical contraindications to physical activity.
Orthopedic problems or other conditions limiting physical fitness assessment or currently pregnant.
Patients who underwent antibiotic/anti-inflammatory treatments in the last 3 months
Trial design
Parallel
Treatments tested in this trial
Mediterranean diet lessons program
BehavioralParticipants will attend five one-hour lessons delivered by qualified professionals to learn about foods that have a positive impact on cognitive function and how to incorporate them into their dietary regimen.
Physical activity
BehavioralParticipants will undergo a 12-week physical exercise program guided by specified personal trainers.
Treatment groups
Trial outcomes
Primary outcomes
MADR Scale for Depression
The Montgomery-Åsberg Depression Rating Scale (MADRS) is a clinician-administered scale designed to assess the severity of depressive symptoms. It consists of 10 items, each rated on a scale from 0 to 6, yielding a total score ranging from 0 to 60. Higher scores indicate greater severity of depression, meaning a worse clinical outcome.
Beck Depression Inventory - II
The Beck Depression Inventory (BDI) is a self-report questionnaire used to assess the presence and severity of depressive symptoms. It comprises 21 items, each rated on a scale from 0 to 3, resulting in a total score ranging from 0 to 63. Higher scores reflect more severe depressive symptoms, indicating a worse clinical outcome.
Zung Self-Rating Depression Scale
The Zung Self-Rating Depression Scale (ZRS) is a self-administered questionnaire designed to assess the level of depressive symptoms in individuals. It consists of 20 items, each rated on a scale from 1 to 4, based on how often symptoms are experienced. The raw total score ranges from 20 to 80, which is often converted to an index score (ranging from 25 to 100) by multiplying the raw score by 1.25. Higher scores indicate more severe depression
Personal and Social Performance Scale
The Personal and Social Performance Scale (PSP) is a clinician-rated instrument used to assess personal and social functioning in individuals with mental disorders. The total score ranges from 1 to 100, with higher scores indicating better functioning and a more favorable clinical outcome.
Secondary outcomes
Immunitary-related factors levels
Plasma/serum levels of cytokines
Gut Microbiome Composition
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: